[Research Report] The precision diagnostics market is projected to reach US$ 168,405.71 million by 2028 from US$ 79,776.88 million in 2022; it is expected to grow at a CAGR of 13.3% from 2022 to 2028.
Precision diagnostics are disease diagnosis methods that explain the patient’s condition in a detailed and precise manner. It helps healthcare professionals to carry out treatment procedures in an effective and efficient manner. It is used to cure diabetes, cancer, and other disorders using various tests, including esoteric tests, genetic tests, and others.
The precision diagnostics market is segmented on the basis of type, application, end user, and geography. By geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and the SAM The precision diagnostics market report offers insights and in-depth analysis of the market, emphasizing parameters including market size, trends, technological advancements, and market dynamics. It also provides the competitive landscape analysis of leading market players across the world. Furthermore, the report includes the impact of the COVID-19 pandemic on the precision diagnostics market across all the regions.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Precision Diagnostics Market: Strategic Insights
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Precision Diagnostics Market: Strategic Insights
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
The growth of the precision diagnostics market is attributed to the increasing number of pipeline studies to develop a new cancer treatment and government initiatives to create awareness regarding precision diagnostics among the community health worker. However, the high cost associated with diagnosis and precision medicine restricts the market growth.
Market Insights
Rising Application in Oncology and Other Disorders Drives Precision Diagnostics Market Growth
Rising Application in Oncology and Other Disorders Drives Precision Diagnostics Market Growth
The precision medicine concept is being applied robustly in the care of rare diseases. Although it is more popular in oncology, it is gradually spreading to other specialties. The rising prevalence of cancer and the growing incidence of rare neurological disorders are increasing the demand for precision medicine, which is driving the growth of the global precision diagnostics market. Further, as per the Neurological Alliance, about 14.7 million neurological cases were registered in 2019, with at least 1 in 6 people suffering from one or more neurological conditions. According to the National Cancer Institute, the number of new cancer cases is projected to rise to 29.5 million by 2040, with cancer-related deaths increasing by 16.4 million. As per World Health Organization (WHO), Alzheimer disease, the most common form of dementia, contributes to nearly 60-70% of cases. Furthermore, as of September 2021, more than 55 million people live with dementia worldwide, accounting for nearly 10 million new cases yearly. In addition, the rising demand for treatment procedures in oncology and other disorders is surging the adoption of treatment procedures.
Moreover, the growing number of strategic collaborations between biopharmaceutical companies to develop medicines targeted to treat a specific group of patients based on their specific needs and to provide effective treatment procedures and services is increasing the number of clinical trials. For instance, Personal Genome Diagnostics Inc. and Massachusetts General Hospital collaborated to advance the development of effective treatment services in 2021. In April 2022, the Precision Cancer Consortium (PCC) is formed as a new collaboration of pharmaceutical companies with a shared vision of providing comprehensive testing to all cancer patients worldwide. Thus, rising application in oncology and other disorders drives precision diagnostics market growth.
Type-Based Insights
Based on type, the precision diagnostics market is segmented into genetic tests, esoteric tests, and others. In 2022, the genetic tests segment holds the largest share of the market. Moreover, the same segment is expected to register the highest CAGR of 13.8 % during the forecast period.
Application-Based Insights
Based on application, the precision diagnostics market is segmented into oncology, cardiology, respiratory diseases, immunology, and others. The oncology segment holds the largest market share in 2022. Moreover, the same segment is anticipated to register the highest CAGR of 13.8% during the forecast period.
End User-Based Insights
Based on end user, the precision diagnostics market is segmented into clinical laboratories, hospitals, homecare, and others. The clinical laboratories segment holds the largest market share in 2022. Moreover, the same segment is anticipated to register the highest CAGR of 13.8% during the forecast period.
The precision diagnostics market players focus on adopting organic strategies, including product launch and expansion, to expand their footprint and product portfolio worldwide and meet the growing demands.
Event Management Platform Market Report ScopePrecision Diagnostics Market Regional Insights
Precision Diagnostics Market Regional Insights
The regional trends and factors influencing the Precision Diagnostics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Precision Diagnostics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
- Get the Regional Specific Data for Precision Diagnostics Market
Precision Diagnostics Market Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 79.78 Billion |
| Market Size by 2028 | US$ 168.41 Billion |
| Global CAGR (2022 - 2028) | 13.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Market Players Density: Understanding Its Impact on Business Dynamics
The Precision Diagnostics Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Precision Diagnostics Market are:
- Quest Diagnostics Incorporated
- QIAGEN
- Swiss Precision Diagnostics GmbH
- Koninklijke Philips N.V.
- Lantheus Medical Imaging, Inc.
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Precision Diagnostics Market top key players overview
By Geography
Based on geography, the precision diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Company Profiles
- Quest Diagnostics Incorporated
- QIAGEN
- Swiss Precision Diagnostics GmbH
- Koninklijke Philips N.V.
- Lantheus Medical Imaging, Inc.
- Siemens Healthineers AG
- Abbott
- Novartis AG
- Sanofi
- Bayer AG
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Precision diagnostics are disease diagnosis methods that explain the patient’s condition in a detailed and precise manner. It helps healthcare professionals to carry out treatment procedures in an effective and efficient manner. It is used to cure diabetes, cancer, and other disorders using various diagnostics tests.
The factors that are driving the growth of market are increasing demands of precision medicines and rising application of precision diagnostics. However, high investments involved in the R&D of precision medicine and diagnostic kits is the major factor hindering the precision diagnostics market growth.
The precision diagnostics market majorly consists of the players, such as Quest Diagnostics Incorporated; QIAGEN; Swiss Precision Diagnostics GmbH; Koninklijke Philips N.V.; Lantheus Medical Imaging, Inc.; Siemens Healthineers AG; Abbott; Novartis AG; Sanofi; and Bayer AG.
The market is estimated to grow at a CAGR of 13.3% during the forecast period.
The precision diagnostics market is estimated to be valued at US$ 79,776.88 million in 2022.
The precision diagnostics market is expected to be valued at US$ 168,405.71 million in 2028.
North America accounts for the major market share of precision diagnostics market in 2022 due to increasing prevalence of cancer and chronic cases in the region and increasing initiatives by government and companies operating in the country.
The colorectal cancer market is analyzed in the basis of type, application, and end user. Based on type, the market is segmented into genetic tests, esoteric tests, and others. The genetic tests segment held the largest share of the market. Moreover, the same segment is anticipated to register the highest CAGR in the forecast period.
Asia Pacific is expected to be the fastest growing region in precision diagnostics market over the forecast period due to developing healthcare infrastructure, enormous population base, growing prevalence of chronic diseases, growing government efforts, and technological improvement in the sector.
Trends and growth analysis reports related to Pharmaceuticals : READ MORE..
The List of Companies - Precision Diagnostics Market
- Quest Diagnostics Incorporated
- QIAGEN
- Swiss Precision Diagnostics GmbH
- Koninklijke Philips N.V.
- Lantheus Medical Imaging, Inc.
- Siemens Healthineers AG
- Abbott
- Novartis AG
- Sanofi
- Bayer AG
Get Free Sample For